[1] Tan M, Bhadoria A S, Cui F, et al. Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol,2021,6(2):106-119. [2] Testoni B, Lebosse F, Scholtes C, et al. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients. J Hepatol,2019,70(4):615-625. [3] Gulbay M, Ciliz D S, Celikbas A K, et al. Intravoxel incoherent motion parameters in the evaluation of chronic hepatitis B virus-induced hepatic injury: fibrosis and capillarity changes. Abdom Radiol (NY),2020,45(8):2345-2357. [4] Kayadibi H, Yilmaz B, Ozgur Y A, et al. Development and evaluation of a novel noninvasive index for predicting significant fibrosis, advanced fibrosis, and cirrhosis in patients with chronic hepatitis B infection. Eur J Gastroenterol Hepatol,2021,33(1):e121-e130. [5] 梁程飞,常宇南,彭小蓉,等. 慢性乙型肝炎儿童肝脏病理特征分析及其肝纤维化非侵入性指标探索. 中华肝脏病杂志,2021,29(6):551-557. [6] Yue W, Li Y, Geng J, et al. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B. Medicine (Baltimore),2019,98(49):180-182. [7] Dong B, Huang S, Chang J, et al. Comparison of sound touch elastography, sound touch quantify, and 4 serum fibrosis indexes for the diagnosis of liver fibrosis in patients with chronic hepatitis B. Ultrasound Q,2021,37(2):123-128. [8] Dong B, Lyu G, Chen Y, et al. Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: a meta-analysis. Expert Rev Gastroenterol Hepatol,2021,15(9):1077-1089. [9] 中华医学会感染病学分会,中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版). 实用肝脏病杂志,2020,23(1):9-32. [10] Zhu Y F, Tan Y F, Xu X, et al. Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study. Medicine (Baltimore),2019,98(50):183-189. [11] 中国中西医结合学会肝病专业委员会. 肝纤维化中西医结合诊疗指南(2019年版). 中华肝脏病杂志,2019,27(7):494-504. [12] Sobhy A, Fakhry M M, Aih A H, et al. Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus. J Investig Med,2019,67(3):681-685. [13] Liu X, Li H, Wei L, et al. Optimized cutoffs of gamma-glutamyl transpeptidase-to-platelet ratio, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 scoring systems for exclusion of cirrhosis in patients with chronic hepatitis B. Hepatol Commun,2022,6(7):1664-1672. [14] Calvopina D A, Lewindon P J, Ramm L E, et al. Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric cystic fibrosis. J Cyst Fibros,2022,21(2):236-242. [15] Aksakal M, Oktar S O, Sendur H N, et al. Diagnostic performance of 2D shear wave elastography in predicting liver fibrosis in patients with chronic hepatitis B and C: a histopathological correlation study. Abdom Radiol (NY),2021,46(7):3238-3244. [16] Sahin T, Serin A, Emek E, et al. Effectiveness of noninvasive fibrosis markers for the prediction of hepatocellular carcinoma in chronic hepatitis B and chronic hepatitis B+D induced cirrhosis. Transplant Proc,2019,51(7):2397-2402. [17] Jin K, Wang H, Zeng M, et al. A comparative study of MR extracellular volume fraction measurement and two-dimensional shear-wave elastography in assessment of liver fibrosis with chronic hepatitis B. Abdom Radiol (NY),2019,44(4):1407-1414. [18] Baldea V, Sporea I, Tudor A, et al. Virtual touch quantification using acoustic radiation force impulse imaging technology versus transient elastography for the noninvasive assessment of liver fibrosis in patients with chronic hepatitis B or C using liver biopsy as the gold standard. J Gastrointestin Liver Dis,2020,29(2):181-190. [19] Kim M N, Lee J H, Chon Y E, et al. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy. Eur J Gastroenterol Hepatol,2020,32(3):433-439. [20] Liu J, Li Y, Yang X, et al. Comparison of two-dimensional shear wave elastography with nine serum fibrosis indices to assess liver fibrosis in patients with chronic hepatitis B: a prospective cohort study. Ultraschall Med,2019,40(2):237-246. |